173 related articles for article (PubMed ID: 17632515)
1. Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR.
Meisner NC; Hintersteiner M; Mueller K; Bauer R; Seifert JM; Naegeli HU; Ottl J; Oberer L; Guenat C; Moss S; Harrer N; Woisetschlaeger M; Buehler C; Uhl V; Auer M
Nat Chem Biol; 2007 Aug; 3(8):508-15. PubMed ID: 17632515
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.
Saunus JM; French JD; Edwards SL; Beveridge DJ; Hatchell EC; Wagner SA; Stein SR; Davidson A; Simpson KJ; Francis GD; Leedman PJ; Brown MA
Cancer Res; 2008 Nov; 68(22):9469-78. PubMed ID: 19010922
[TBL] [Abstract][Full Text] [Related]
3. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
[TBL] [Abstract][Full Text] [Related]
4. Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer.
Woo HH; Zhou Y; Yi X; David CL; Zheng W; Gilmore-Hebert M; Kluger HM; Ulukus EC; Baker T; Stoffer JB; Chambers SK
Oncogene; 2009 Mar; 28(9):1176-86. PubMed ID: 19151756
[TBL] [Abstract][Full Text] [Related]
5. Activity-dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain.
Tiruchinapalli DM; Caron MG; Keene JD
J Neurochem; 2008 Dec; 107(6):1529-43. PubMed ID: 19014379
[TBL] [Abstract][Full Text] [Related]
6. HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence.
Ortega AD; Sala S; Espinosa E; González-Barón M; Cuezva JM
Carcinogenesis; 2008 Nov; 29(11):2053-61. PubMed ID: 18687667
[TBL] [Abstract][Full Text] [Related]
7. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol.
Choi HJ; Yang H; Park SH; Moon Y
Toxicol Appl Pharmacol; 2009 Oct; 240(1):46-54. PubMed ID: 19591856
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
[TBL] [Abstract][Full Text] [Related]
9. Expression of HuR in Merkel cell carcinoma and in normal skin.
Koljonen V; Böhling T; Haglund C; Ristimäki A
J Cutan Pathol; 2008 Jan; 35(1):10-4. PubMed ID: 18095988
[TBL] [Abstract][Full Text] [Related]
10. Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma: association with cyclooxygenase-2 and prognosis.
Stoppoloni D; Cardillo I; Verdina A; Vincenzi B; Menegozzo S; Santini M; Sacchi A; Baldi A; Galati R
Cancer; 2008 Nov; 113(10):2761-9. PubMed ID: 18831511
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas.
Cho NP; Han HS; Soh Y; Lee KY; Son HJ
Pathology; 2007 Dec; 39(6):545-50. PubMed ID: 18027256
[TBL] [Abstract][Full Text] [Related]
12. HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.
Yi X; Zhou Y; Zheng W; Chambers SK
Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):93-8. PubMed ID: 19281587
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of HuR in hereditary breast cancer.
Heinonen M; Fagerholm R; Aaltonen K; Kilpivaara O; Aittomäki K; Blomqvist C; Heikkilä P; Haglund C; Nevanlinna H; Ristimäki A
Clin Cancer Res; 2007 Dec; 13(23):6959-63. PubMed ID: 18056170
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression.
Chemnitz J; Pieper D; Grüttner C; Hauber J
Eur J Immunol; 2009 Jan; 39(1):267-79. PubMed ID: 19130553
[TBL] [Abstract][Full Text] [Related]
15. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
[TBL] [Abstract][Full Text] [Related]
16. The Elav-like protein HuR exerts translational control of viral internal ribosome entry sites.
Rivas-Aravena A; Ramdohr P; Vallejos M; Valiente-Echeverría F; Dormoy-Raclet V; Rodríguez F; Pino K; Holzmann C; Huidobro-Toro JP; Gallouzi IE; López-Lastra M
Virology; 2009 Sep; 392(2):178-85. PubMed ID: 19647848
[TBL] [Abstract][Full Text] [Related]
17. A dual-mode fluorescence strategy for screening HAT modulators.
Xie N; Elangwe EN; Asher S; Zheng YG
Bioconjug Chem; 2009 Feb; 20(2):360-6. PubMed ID: 19146394
[TBL] [Abstract][Full Text] [Related]
18. Identification of N,N-arylalkyl-picolinamide derivatives targeting the RNA-binding protein HuR, by combining biophysical fragment-screening and molecular hybridization.
Della Volpe S; Linciano P; Listro R; Tumminelli E; Amadio M; Bonomo I; Elgaher WAM; Adam S; Hirsch AKH; Boeckler FM; Vasile F; Rossi D; Collina S
Bioorg Chem; 2021 Nov; 116():105305. PubMed ID: 34482166
[TBL] [Abstract][Full Text] [Related]
19. A modified quantitative EMSA and its application in the study of RNA--protein interactions.
Li Y; Jiang Z; Chen H; Ma WJ
J Biochem Biophys Methods; 2004 Aug; 60(2):85-96. PubMed ID: 15262445
[TBL] [Abstract][Full Text] [Related]
20. PMA induces stabilization of oncostatin M mRNA in human lymphoma U937 cells.
Bandyopadhyay S; Sengupta TK; Spicer EK
Biochem J; 2008 Feb; 410(1):177-86. PubMed ID: 17924856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
